0
Business
Which Dividend Pharma Stock Should a Value Investor Choose Today?
April 13, 2026
The Motley Fool
Scroll
Bristol Myers Squibb looks like a value buy, so long as its pipeline remains strong.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left